HPTN Publications

Abdool Karim Q, Sibeko S, Baxter C . Preventing HIV infection in women: a global health imperative. Clin Infect Dis. 2010, 50: S122-9. PMC3021824
Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L; HIV Prevention Trials Network (HPTN) 035 Study Team . Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011, 25: 957-99. PMC3063640
Abler L, Hill L, Maman S, DeVellis R, Twine R, Kahn K, MacPhail C, Pettifor A . Hope Matters: Developing and Validating a Measure of Future Expectations Among Young Women in a High HIV Prevalence Setting in Rural South Africa (HPTN 068). AIDS and Behavior. 2017, 21: 2156-2166. PMC5626443
Aboud S, Msamanga G, Read JS, Mwatha A, Chen YQ, Potter D, Valentine M, Sharma U, Hoffman I, Taha TE, Goldenberg RL, and Fawzi WW . Genital Tract Infection Among HIV-infected Pregnant Women in Malawi, Tanzania and Zambia. Int J STD AIDS. 2008, 19: 824-32. PMC2698963
Aboud S, Msamanga G, Read JS, Wang L, Mfalila C, Sharma U, Martinson F, Taha TE, Goldenberg RL, Fawzi WW . Effect of prenatal and perinatal antibiotics on maternal health in Malawi, Tanzania, and Zambia. Int J Gynecol Obstet. 2009, 107: 202-07. PMC2783250
Adamson B, El-Sadr W, Dimitrov D, Gamble T, Beauchamp G, Carlson J, Garrison L, Donnell D . The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study. Value in Health. 2019, 22: 194-202. PMC6362462
Adimora AA, Hughes JP, Wang J, Haley DF, Golin CE, Magnus M, Rompalo A, Justman J, Del Rio C, El-Sadr W, Mannheimer S, Soto-Torres L, Hodder SL; for the HPTN 064 Protocol Team . Characteristics of Multiple and Concurrent Partnerships among
Women at High Risk for HIV Infection
. J Acquir Immune Defic Syndr. 2014, 65: 99-106. PMC4172374
Adimora AA, Ramirez C, Auerbach JD, Aral SO, Hodder S, Wingood G, El-Sadr W, Bukusi EA; HIV Prevention Trials Network Women at Risk Committee . Preventing HIV infection in women. J Acquir Immune Defic Syndr. 2013, 63: S168-73. PMC4084712
Aizire J, Fowler MG, Wang J, Shetty AK, Stranix-Chibanda L, Kamateeka M, Brown ER, Bolton SG, Musoke PM, Coovadia H . Extended prophylaxis with nevirapine and cotrimoxazole among HIV-exposed uninfected infants is well tolerated. AIDS. 2012, 26: 325-33. PMC3356697
Amico KR, Ramirez C, Caplan MR, Montgomery BE, Stewart J, Hodder S, Swaminathan S, Wang J, Darden-Tabb NY, McCauley M, Mayer KH, Wilkin T, Landovitz RJ, Gulick R, Adimora AA, HPTN 069/A5305 Study Team, HPTN Women at Risk Committee . Perspectives of US women participating in a candidate PrEP study: adherence, acceptability and future use intentions. J Int AIDS Soc. 2019, 22: e25247. PMC6416666
Ann O'Leary and Paula M. Frew (Eds.) . Poverty in the United States. 2016
Avery LB, Bakshi RP, Cao YJ, Hendrix CW . The male genital tract is not a pharmacological sanctuary from efavirenz. Clin Pharmacol Ther. 2011, 90: 151-56. PMC3215581
Baeten JM, Haberer JE, Liu AY, Sista N . Preexposure prophylaxis for HIV prevention: where have we been and where are we going?. J Acquir Immune Defic Syndr. 2013, 63: S122-9. PMC3710117
Baeten JM, Richardson BA, Martin HL Jr, Nyange PM, Lavreys L, Ngugi EN, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK . Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: implications for HIV-1 vaccine efficacy trials. Journal of AIDS. 2000, 24: 458-64
Balakrishnan P, Solomon S, Mohanakrishnan J, Cecelia AJ, Kumarasamy N, Murugavel KG, Venkatakrishnan B, Solomon SS, Crowe SM, Ganesh AK, Thyagarajan SP, Flanigan T, Mayer KH . A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. J Acquir Immune Defic Syndr. 2006, 43: 23-6 PMID: 16885780
Barresi P, Husnik M, Camacho M, Powell B, Gage R, LeBlanc D, Verano P, Chesney M, Koblin B . Recruitment of men who have sex with men for large HIV intervention trials: analysis of the EXPLORE Study recruitment effort. AIDS Educ Prev. 2010, 22: 28-36. PMC3114877
Batra M, Tien PC, Shafer RW, Contag CH, Katzenstein DA . HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe. AIDS Res Hum Retroviruses. 2000, 16: 973-9
Becker-Pergola G, Mellquist JL, Guay L, Mmiro F, Ndugwa C, Kataaha P, Jackson JB, Eshleman SH . Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women. AIDS Res Hum Retroviruses. 2000, 16: 1099-04
Bedoya CA, Mimiaga MJ, Beauchamp G, Donnell D, Mayer KH, Safren SA . Predictors of HIV transmission risk behavior and seroconversion among Latino men who have sex with men in Project EXPLORE. AIDS Behav. 2012, 16: 608-17. PMC3632284
Bekker LG, Roux S, Sebastien E, Yola N, Amico KR, Hughes JP, Marzinke MA, Hendrix CW, Anderson PL, Elharrar V, Stirratt M, Piwowar-Manning E, Eshleman SH, McKinstry L, Li M, Dye BJ, Grant RM, for the HPTN 067/ADAPT Cape Town study team . Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial. Lancet. 2018, 5: e68-e78. PMC6107917
Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, M, Mulligan M, Wright P, Celum C, Judson F, Mayer K, McKirnan D, Marmor M, Woody G, National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET) . Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers. J Infect Dis. 2001, 183: 1343-52
Bentley ME, Fullem AM, Tolley EE, Kelly CW, Jogelkar N, Srirak N, Mwafulirwa L, Khumalo-Sakutukwa G, Celentano DD . Acceptabilty of a microbicide among women and their partners in a 4-country phase 1 trial. Am J Public Health. 2004, 94: 1159-64
Bentley ME, Morrow KM, Fullem A, Chesney MA, Horton SD, Rosenberg Z, Mayer KH . Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect. 2000, 32: 184-8
Bentley ME, Spratt K, Shepherd ME, Gangakhedkar RR, Thilikavathi S, Bollinger RC, Mehendale SM . HIV testing and counseling among men attending STD clinics in Pune, India: Changes in condom use and sexual behavior over time. AIDS. 1998, 12: 1869-1877
Blackstock OJ, Frew P, Bota D, Vo-Green L, Parker K, Franks J, Hodder SL, Justman J, Golin CE, Haley DF, Kuo I, Adimora AA, Rompalo A, Soto-Torres L, Wang J, Mannheimer SB . Perceptions of Community HIV/STI Risk Among U.S Women Living in Areas with High Poverty and HIV Prevalence Rates.. J Health Care Poor Underserved. 2015, 26: 811-823. PMC4607276
Bock P, Fatti G, Ford N, Jennings K, Kruger J, Gunst C, Louis F, Grobbelaar N, Shanaube K, Floyd S, Grimwood A, Hayes R, Ayles H, Fidler S, Beyers N, for the HPTN 071 Study Team . Attrition when providing antiretroviral treatment at CD4 counts >500cells/muL at three government clinics included in the HPTN 071 (PopART) trial in South Africa. PLoS One. 2018, 13: e0195127. PMC5909512
Bock P, Jennings K, Vermaak R, Cox H, Meintjes G, Fatti G, Kruger J, De Azevedo V, Maschilla L, Louis F, Gunst C, Grobbelaar N, Dunbar R, Limbada M, Floyd S, Grimwood A, Ayles H, Hayes R, Fidler S, Beyers N . Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa. J Acquir Immune Defic Syndr. 2018, 77: 93-101. PMC5720907
Bock P, Nel K, Fatti G, Sloot R, Ford N, Voget J, Gunst C, Grobbelaar N, Louis F, Floyd S, Hayes R, Ayles H, Beyers N, Fidler S, HPTN 071 Study Team . Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HPTN 071; PopART study in South Africa.
Bock P, Phiri C, Piwowar Manning E, Kosloff B, Mandla N, Young A, Scheepers M, Donnel D, Griffith S, El-Sadr WM, Beyers N, Shanaube K, Hayes R, Fidler S, Ayles H, on behalf of the HPTN 071 (PopART) Study Team . Understanding low sensitivity of community based HIV rapid testing: Experiences from the HPTN 071(PopART) Trial in Zambia and South Africa. J Int AIDS Soc. 2017, 20: 21780. PMC5625636
Bond V, Chiti B, Hoddinott G, Reynolds L, Schaap A, Simuyaba M, Ndubani R, Viljoen L, Simwinga M, Fidler S, Hayes R, Ayles H, Seeley J, for the HPTN 071 Study Team . "The difference that makes a difference": highlighting the role of variable contexts within an HIV Prevention Community Randomised Trial (HPTN 071/PopART) in 21 study communities in Zambia and South Africa. AIDS Care. 2016, 28: 99-107
Bond V, Ngwenya F, Murray E, Ngwenya N, Viljoen L, Gumede D, Bwalya, Mantantana J, Hoddinott G, Dodd PJ, Ayles H, Simwinga M, Wallman S, Seeley J . Value and Limitations of Broad Brush Surveys Used in Community-Randomized Trials in Southern Africa. 2019. PMC6533803
Bond V, Ngwenya F, Thomas A, Simuyaba M, Hoddinott G, Fidler S, Hayes R, Ayles H, Seeley J, HPTN 071 Study Team . Spinning plates: livelihood mobility, household responsibility and anti-retroviral treatment in an urban Zambian community during the HPTN 071 (PopART) study. J Int AIDS Soc. 2018, 21 Suppl 4: e25117. PMC6053474
Bond V, Nomsenge S, Mwamba M, Ziba D, Birch A, Mubekapi-Musadaidzwa C, Vanqa N, Viljoen L, Pliakas T, Ayles H, Hargreaves J, Hoddinott G, Stangl A, Seeley J, HPTN 071 (PopART) study team . "Being seen" at the clinic: Zambian and South African health worker reflections on the relationship between health facility spatial organisation and items and HIV stigma in 21 health facilities, the HPTN 071 (PopART) study. Health Place. 2019, 55: 87-99. PMC6358039
Bradley J, Floyd S, Piwowar-Manning E, Laeyendecker O, Young A, Bell-Mandla N, Bwalya J, Bock P, Fidler S, Ayles H, Hayes RJ, HPTN 071 Study Team, HPTN 071 (PopART) Study Team . Sexually Transmitted Bedfellows: Exquisite Association Between HIV and Herpes Simplex Virus Type 2 in 21 Communities in Southern Africa in the HIV Prevention Trials Network 071 (PopART) Study. J Infect Dis. 2018, 218: 443-452. PMC6049005
Brahmi A, Reid C, Mass B, Kelly C . Meeting Retention Challenges in Lusaka Zambia. Research Practitioner. 2006, 7: 212-13
Branson B, Chavez PR, Hanscom B, Greene E, McKinstry L, Buchacz K, Beauchamp G, Gamble T, Zingman BS, Telzak E, Naab T, Fitzpatrick L, El-Sadr WM, for the HPTN 065 study team . Expanding Hospital Human Immunodeficiency Virus Testing in the Bronx, New York and Washington, District of Columbia: Results From the HPTN 065 Study. Clin Infect Dis. 2018, 66: 1581-1587. PMC5930256
Branson BM, Viall A, Marum E . Expanding HIV testing: back to the future. J Acquir Immune Defic Syndr. 2013, 63: S117-21
Brewer RA, Magnus M, Kuo I, Wang L, Liu TY, Mayer KH . Exploring the relationship between incarceration and HIV among Black men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2014, 65: 218-25. PMC3898433
Brewer RA, Magnus M, Kuo I, Wang L, Liu TY, Mayer KH . The high prevalence of incarceration history among black men who have sex with men in the United States: associations and implications. Am J Public Health. 2014, 104: 448-54. PMC3953792
Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH . Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol. 2013, 177: 264-72. PMC3626051
Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH . Cross-sectional HIV incidence estimation in HIV prevention research. J Acquir Immune Defic Syndr. 2013, 63: S233-9. PMC3737594
Brown E, Chi BH, Read JS, Taha T, Sharma U, Hoffman IF, Pikora C, Goldenberg RL, Fiscus S . Determining an optimal testing strategy for infants at risk for mother-to-child transmission of HIV-1 during the late postnatal period. AIDS. 2008, 22: 2341-6. PMC2760032
Brown EL, Wald A, Hughes JP, Morrow RA, Krantz E, Mayer K, Buchbinder S, Koblin B, Celum C . High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol. 2006, 164: 733-41 PMID 16896053
Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E . Determinants of Enrollment in a Preventive HIV Vaccine Trial: Hypothetical Versus Actual Willingness and Barriers to Participation. J Acquir Immune Defic Syndr. 2004, 36: 604-12
Caliendo AM, Valsamakis A, Bremer JW, Ferreira-Gonzalez A, Granger S, Sabatini L, Tosongalis GJ, Wang YF, Yen-Lieberman B, Young S, Lurain NS . Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification. J Clin Micro. 2011, 49: 2854-58. PMC3147738
Camlin CS, Seeley J, Viljoen L, Vernooij E, Simwinga M, Reynolds L, Reis R, Plank R, Orne-Gliemann J, McGrath N, Larmarange J, Hoddinott G, Getahun M, Charlebois ED, Bond V . Strengthening universal HIV 'test-and-treat' approaches with social science research. AIDS. 2016, 30: 969-70. PMC4794132
Cao H, Kaleebu P, Hom D, Flores J, Agrawal D, Jones N, Serwanga J, Okello M, Walker C, Sheppard H, El-Habib R, Klein M, Kebba A, Salata R, Mbidde E, Mugyenyi P, Walker B, Ellner J, Mugerwa R, and the HIV Network for Prevention Trials . Immunogenicity of a Recombinant Human Immunodeficiency Virus (HIV)-Canarypox Vaccine in HIV-Seronegative Ugandan Volunteers: Results of the HIV Network for Prevention Trials 007 Vaccine Study. J Infect Dis. 2003, 187: 887-95
Cao YJ, Caffo B, Choi L, Radebaugh CL, Fuchs EJ, Hendrix CW . Noninvasive quantitation of drug concentration in prostate and seminal vesicles: improvement and validation with desipramine and aspirin. J Clin Pharmacol. 2007, 48: 176-83
Cao YJ, Ndovi TT, Parsons TL, Guidos AM, Caffo B, Hendrix CW . Effect of semen sampling frequency on seminal antiretroviral drug concentration. Clin Pharmacol Ther. 2008, 83: 848-56
Carballo-Diéguez A, Balán IC, Morrow K, Rosen R, Mantell JE, Gai F, Hoffman S, Maslankowski L, El-Sadr W, Mayer K . Acceptability of tenofovir gel as a vaginal microbicide by US male participants in a Phase I clinical trial (HPTN 050). AIDS Care. 2007, 19: 1026-31 PMID: 17852000
Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C . HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: baseline data from the EXPLORE Study. Sex Transm Infect. 2006, 82: 229-35. PMC2564745
Casper C, Wald A, Pauk J, Tabet SR, Corey L, Celum CL . Correlates of prevalent and incident kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis. 2002, 185: 990-3
Cates W Jr, Allen M . Mother-to-child HIV-1 transmission. Lancet. 2000, 356: 945
Cavacini LA, Peterson JE, Nappi E, Duval M, Goldstein R, Mayer K, Posner MR . Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals. J Virol. 1999, 73: 9638-41. PMC113002
Celentano DD, Bond KC, Lyles CM, Eiumtrakul S, Go VF, Beyrer C, na Chiangmai C, Nelson KE, Khamboonruang C, Vaddhanaphuti C . Preventive intervention to reduce sexually transmitted infections: a field trial in the Royal Thai Army. Arch Intern Med. 2000, 160: 535-40
Celum C, Baeten JM, Hughes JP, Barnabas R, Liu A, Van Rooyen H, Buchbinder S . Integrated strategies for combination HIV prevention: principles and examples for men who have sex with men in the Americas and heterosexual African populations. J Acquir Immune Defic Syndr. 2013, 63: S213-20. PMC3708491
Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia, M, Ortiz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L, HPTN 039 Protocol Team . Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet. 2008, 371: 2109-19.. PMC2650104
Celum CL, Buchbinder SP, Donnell D, Douglas JM Jr, Mayer K, Koblin B, Marmor M, Bozeman S, Grant RM, Flores J, Sheppard HW . Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load. J Infect Dis. 2001, 183: 23-35
Chasela C, Chen YQ, Fiscus S, Hoffman I, Young A, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JS . Risk Factors for Late Postnatal Transmission of Human Immunodeficiency Virus Type 1 in Sub-Saharan Africa. Pediatr Infect Dis J. 2008, 27: 251-6.. PMC2730543
Chemnasiri T, Varangrat A, Amico KR, Chitwarakorn A, Dye BJ, Grant RM, Holtz TH, HPTN 067/ADAPT Study Team . Facilitators and barriers affecting PrEP adherence among Thai men who have sex with men (MSM) in the HPTN 067/ADAPT Study. AIDS Care. 2019, 1-6
Chen I, Chau G, Wang J, Clarke W, Marzinke MA, Cummings V, Breaud A, Laeyendecker O, Fields SD, Griffith S, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . Analysis of HIV Diversity in HIV-Infected Black Men Who Have Sex with Men (HPTN 061). PLoS One. 2016, 11: e0167629. PMC5147928
Chen I, Clarke W, Ou SS, Marzinke MA, Breaud A, Emel LM, Wang J, Hughes JP, Richardson P, Haley DF, Lucas J, Rompalo A, Justman JE, Hodder SL, Eshleman SH . Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064. PLoS One. 2015, 10: e0140074. PMC4596522
Chen I, Connor MB, Clarke W, Marzinke MA, Cummings V, Breaud A, Fogel JM, Laeyendecker O, Fields SD, Donnell D, Griffith S, Scott HM, Shoptaw S, Rio CD, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . Antiretroviral drug use and HIV drug resistance among HIV-infected Black men who have sex with men: HIV Prevention Trials Network 061. J Acquir Immune Defic Syndr. 2015. PMC4482803
Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Rio CD, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . Low-level Viremia Early in HIV Infection. J Acquir Immune Defic Syndr. 2014, 67: 405-8. PMC4213245
Chen I, Huang W, Connor MB, Frantzell A, Cummings V, Beauchamp GG, Griffith S, Fields SD, Scott HM, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Tieu HV, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061. HIV Clin Trials. 2016, 17: 158-64. PMC5003405
Chen I, Zhang Y, Cummings V, Cloherty GA, Connor M, Beauchamp G, Griffith S, Rose S, Gallant J, Scott HM, Shoptaw S, Del Rio C, Kuo I, Mannheimer S, Tieu HV, Hurt CB, Fields SD, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH . Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States. AIDS Res Hum Retroviruses. 2017, 33: 745-748. PMC5512295
Chen YQ, Masse B, Wang L, Ou SS, Li X, Donnell D, McCauley M, Gamble T, Ribauldo HJ, Cohen MS, Fleming TR . Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples. Contemp Clin Trials. 2012, 33: 1280-6. PMC3468650
Chen YQ, Young A, Brown ER, Chasela CS, Fiscus SA, Hoffman IF, Valentine M, Emel L, Taha TE, Goldenberg RL, Read JS . Population Attributable Fractions for Late Postnatal Mother-to-Child Transmission of HIV-1 in Sub-Saharan Africa. JAIDS. 2010, 54: 311-16. PMC3086731
Chesney MA, Koblin BA, Barresi PJ, Husnik MJ, Celum CL, Colfax G, Mayer K, McKirnan D, Judson FN, Huang Y, Coates TJ . An Individually Tailored Intervention for HIV Prevention: Baseline Data From the EXPLORE Study. Am J Public Health. 2003, 93: 933-8
Chi BH, Wang L, Read JS, Sheriff M, Fiscus S, Brown ER, Taha TE, Valentine M, Goldenberg R . Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024. AIDS. 2005, 19: 1857-64
Chi BH, Wang L, Read JS, Taha TE, Sinkala M, Brown ER, Valentine M, Martinson F, Goldenberg RL . Predictors of stillbirth in sub-saharan Africa. Obstet Gynecol. 2007, 110: 989-97 PMID:17978109
Chilongozi D, Wang L, Brown L, Taha T, Valentine M, Emel L, Sinkala M, Kafulafula G, Noor RA, Read JS, Brown ER, Goldenberg RL, Hoffman I, HIVNET 024 Study Team . Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Pediatr Infect Dis J. 2008, 27: 808-14. PMC2739309
Chin-Hong PV, Husnik M, Cranston RD, Colfax G, Buchbinder S, Da Costa M, Darragh T, Jones D Judson F, Koblin B, Mayer KH, Palefsky JM . Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS. 2009, 23: 1135-42 PMID: 19390418
Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, Palefsky JM . Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst. 2005, 97: 896-05
Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, Da Costa M, Darragh T, Hess E, Judson F, Koblin B, Madison M, Palefsky JM . Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis. 2004, 190: 2070-6 PMID: 19390418
Chingono A, Lane T, Chitumba A, Kulich M, Morin S . Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe. Clin Trials. 2008, 5: 273-6 PMID:18559417
Chirowodza A, van Rooyen H, Joseph P, Sikotoyi S, Richter L, Coates T . Using Participatory Methods and Geographic Information Systems (Gis) to Prepare for an HIV Community-based Trial in Vulindlela, South Africa (Project Accept-HPTN 043. Journal of Community Psychology. 2009, 37: 41-57. PMC2747527
Christerson L, Bom RJM, Bruisten SM, Yass R, Hardick J, Bratt G, Gaydos CA, Morré SA, Herrmann B . Chlamydia trachomatis strains show specific clustering for men who have sex with men compared to heterosexual transmission in Sweden, the Netherlands, and the United States. J Clin Microbiol. 2012, 50: 3548-55. PMC3486246
Church JD, Eshleman SH . Reply to Krivine et al. J Infect Dis. 2009, 199: 1554-5
Church JD, Huang W, Mwatha A, Musoke P, Jackson JB, Bagenda D, Omer SB, Donnell D, Nakabiito C, Eure C, Guay LA, Taylor A, Bakaki PM, Matovu F, McConnell M, Fowler MG, Eshleman SH . Analysis of HIV tropism in Ugandan infants. Curr HIV Res. 2010, 8: 498-503. PMC3075545
Church JD, Huang W, Mwatha A, Toma J, Stawiski E, Donnell D, Guay LA, Mmiro F, Musoke P, Jackson JB, Parkin N, Eshleman SH . HIV-1 tropism and survival in vertically infected Ugandan infants. J Infect Dis. 2008, 197: 1382-8. PMC3075545
Church JD, Huang W, Parkin N, Marlowe N, Guay LA, Omer SB, Musoke P, Jackson JB, Eshleman SH . Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants. AIDS Res Hum Retroviruses. 2009, 25: 657-63. PMC2799186
Church JD, Hudelson SE, Guay LA, Chen S, Hoover DR, Parkin N, Fiscus SA, Mmiro F, Musoke P, Kumwenda N, Jackson JB, Taha TE, Eshleman SH . HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D. AIDS Res Hum Retroviruses. 2007, 23: 764-68 PMID 17604538
Church JD, Jones D, Flys T, Hoover D, Marlowe N, Chen S, Shi C, Eshleman JR, Guay LA, Jackson JB, Kumwenda N, Taha TE, Eshleman SH . Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D. J Mol Diagn. 2006, 8: 430-2. PMC1867617
Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C, Bakaki P, Matovu F, Thigpen MC, Guay LA, McConnell M, Fowler MG, Jackson JB, and Eshleman SH . In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine. AIDS Res Hum Retroviruses. 2009, 25: 673-7. PMC2752753
Church JD, Omer SB, Guay LA, Huang W, Lidstrom J, Musoke P, Mmiro F, Jackson JB, Eshleman SH . Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. J Infect Dis. 2008, 198: 1075-1082. PMC2587235
Church JD, Towler WI, Hoover DR, Hudelson SE, Kumwenda N, Taha TE, Eshleman JR, Eshleman SH . Comparison of LigAmp and an ASPCR assay for detection and quantification of K103N-containing HIV variants. AIDS Res Hum Retroviruses. 2008, 24: 595-605
Clarke J, Peipert JF, Hillier SH, Heber W, Boardman L, Moench TR, Mayer K . Microflora changes with the use of a vaginal microbicide. Sex Transm Dis. 2002, 29: 288-93
Closson E, Mimiaga M, Sherman S, Tangmunkongvorakul A, Friedman R, Limbada M, Moore A, Srithanaviboonchai K, Alves C, Roberts S, Oldenburg C, Elharrar V, Mayer K, Safren S, Tangmunkongvorakul A, Friedman R, Srithanaviboonchai K . Intimacy versus Isolation: A Qualitative Study of Sexual Practices among Sexually Active HIV-Infected Patients in HIV Care in Brazil, Thailand, and Zambia. PLoS One. 2015, 10. PMC4368566
Coates T . An expanded behavioral paradigm for prevention and treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2013, 63: S179-82. PMC3943341
Coates TJ, Kulich M, Celentano D, Zelaya CE, Chariyalertsak S, Chingono A, Gray G, Mbwambo JK, Morin SF, Richter L, Sweat M, van Rooyen H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szekeres G, Donnell D, Eshleman SH; NIMH Project Accept Team, Eshleman SH, NIMH Project Accept Team . Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial. Lancet Glob Health. 2014, 2: e267-77. PMC4131207
Coates TJ, Richter L, Caceres C . Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet. 2008, 372: 669-84.. PMC2702246